Cargando…
EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061678/ https://www.ncbi.nlm.nih.gov/pubmed/33898930 http://dx.doi.org/10.1097/HS9.0000000000000559 |
| _version_ | 1783681616150790144 |
|---|---|
| author | Ladetto, Marco Dreyling, Martin |
| author_facet | Ladetto, Marco Dreyling, Martin |
| author_sort | Ladetto, Marco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8061678 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80616782021-04-23 EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma Ladetto, Marco Dreyling, Martin Hemasphere Editorial Lippincott Williams & Wilkins 2021-04-21 /pmc/articles/PMC8061678/ /pubmed/33898930 http://dx.doi.org/10.1097/HS9.0000000000000559 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Editorial Ladetto, Marco Dreyling, Martin EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma |
| title | EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma |
| title_full | EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma |
| title_fullStr | EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma |
| title_full_unstemmed | EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma |
| title_short | EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma |
| title_sort | eha endorsement of esmo clinical practice guidelines for newly diagnosed and relapsed follicular lymphoma |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061678/ https://www.ncbi.nlm.nih.gov/pubmed/33898930 http://dx.doi.org/10.1097/HS9.0000000000000559 |
| work_keys_str_mv | AT ladettomarco ehaendorsementofesmoclinicalpracticeguidelinesfornewlydiagnosedandrelapsedfollicularlymphoma AT dreylingmartin ehaendorsementofesmoclinicalpracticeguidelinesfornewlydiagnosedandrelapsedfollicularlymphoma |